financetom
Business
financetom
/
Business
/
Drugmakers agree to participate in second round of price negotiations
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Drugmakers agree to participate in second round of price negotiations
Mar 14, 2025 3:35 PM

March 14 (Reuters) - All drug manufacturers, including

Novo Nordisk and Teva Pharmaceuticals,

whose medicines are part of the second round of price talks have

agreed to participate in the negotiation process, a federal

health agency said on Friday.

(Reporting by Bhanvi Satija and Sneha SK in Bengaluru)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bill Hwang's trial begins over collapse of his $36 billion Archegos fund
Bill Hwang's trial begins over collapse of his $36 billion Archegos fund
May 8, 2024
NEW YORK (Reuters) - Sung Kook Bill Hwang's criminal racketeering trial over the collapse of Archegos Capital Management begins on Wednesday with the selection of jurors who will decide if he and a deputy broke the law in a massive stock scheme that unraveled in just days in 2021. The trial in Manhattan federal court is expected to last up...
Norway adds more acreage for Arctic oil, gas exploration
Norway adds more acreage for Arctic oil, gas exploration
May 8, 2024
OSLO, May 8 (Reuters) - Norway offered 37 new blocks to explore for oil and gas in the Norwegian and the Barents Seas in its so-called APA round, in line with plans first outlined in January, the country's energy ministry said in a statement on Wednesday. ...
RingCentral's Q1 Non-GAAP Earnings, Revenue Advance; 2024 Outlook Boosted
RingCentral's Q1 Non-GAAP Earnings, Revenue Advance; 2024 Outlook Boosted
May 8, 2024
06:10 AM EDT, 05/08/2024 (MT Newswires) -- RingCentral ( RNG ) reported Q1 non-GAAP earnings late Tuesday of $0.87 per diluted share, up from $0.76 a year earlier. Analysts polled by Capital IQ expected $0.80. Revenue for the quarter ended March 31 was $584.2 million, up from $533.7 million a year earlier. Analysts surveyed by Capital IQ expected $578.2 million....
South Korea welcomes US decision to extend use of Chinese graphite in EVs
South Korea welcomes US decision to extend use of Chinese graphite in EVs
May 8, 2024
SEOUL (Reuters) - South Korea on Wednesday welcomed a U.S. decision to extend automakers' eligibility for electric vehicle tax credits for cars containing Chinese graphite through 2026. The U.S. is trying to wean the electric vehicle battery chain away from China through its Inflation Reduction Act which is being closely monitored by automakers as they make investment decisions. South Korea's...
Copyright 2023-2026 - www.financetom.com All Rights Reserved